22.5 C
New York
Thursday, June 18, 2026

Tag: solid

StarCharge Unveils Next-Generation Energy Solutions and Strategic ANZ Partnership at SNEC 2026

SHANGHAI, June 4, 2026 /PRNewswire/ -- StarCharge, a global leader in EV charging and digital energy solutions, showcased its latest smart energy technologies and...

AIDIMM™ & AILPBGA™ Make Global Debut | Longsys Spotlights Full-Stack Edge AI Storage Solutions at COMPUTEX 2026

TAIPEI, June 4, 2026 /PRNewswire/ -- From June 2 to 5, 2026, COMPUTEX 2026 in Taipei runs under the theme "AI Together," focusing on AI...

Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.

Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026

NEWTON, Mass., June 3, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it...

Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage “Micromill” Formulation Platform, Enabling Drug Development Decision With Milligrams of API

New collaboration delivers a fully integrated formulation workflow from early solubility studies to high-throughput dissolution, stability, and in-process analytics, making drug formulation less artisanal...

/C O R R E C T I O N — Capital Community Bank/

In the news release, CCBank Launches Quill Bank to Deliver Banking Expertise to Fintechs, issued 02-Jun-2026 by Capital Community Bank over PR Newswire, we...

Zhihu Inc. Reports Unaudited First Quarter 2026 Financial Results

BEIJING, China, June 03, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended March 31, 2026.

SKHTU Builds US-EU Compliance System, Advancing Global Digital Finance Expansion

DENVER, June 03, 2026 (GLOBE NEWSWIRE) -- The crypto industry is undergoing a shift from “regulation chasing innovation” to “regulation driving innovation.” SKHTU Exchange recently released global compliance strategy that is a reflection of this trend. The focus is on leveraging dual US MSB and SEC licenses, while coordinating with the European MiCA regulatory framework. This approach marks the SKHTU establishment of a cross-system compliance loop within the international regulatory landscape, providing institutional safeguards for global operations.

Statkraft og Elkem inngår syvårig kraftavtale for Bjølvefossen-verket på Vestlandet

(Oslo, 3. juni 2026) Statkraft og Elkem ASA har inngått en ny langsiktig kraftavtale som sikrer konkurransedyktig og forutsigbar krafttilgang til Elkems verk på Bjølvefossen, i Kvam kommune i Vestland. Avtalen gjelder for perioden 2031–2037 og sikrer levering av totalt 1 534 GWh til verket. 

Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026

CHENGDU, China, June 3, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 American Society...

Crescent Biopharma to Present at June Investor Conferences

WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June:

Cocamidopropyl Betaine (CAPB) Market Size to Reach USD 1.45 Billion by 2033, Driven by Growing Demand for Mild Surfactant Systems, Regulatory-Aligned Formulations, and Expanding...

Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSolid